Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA-Revival of a disease-activity marker in autoimmune hepatitis

Clinica Chimica Acta

Volumn 408, Issue 1-2, 2009, Pages 19-24

  Hausdorf, Gert ^a   Roggenbuck, Dirk ^b   Feist, Eugen ^a   Büttner, Thomas ^b   Jungblut, Peter R ^c   Conrad, Karsten ^d   Berg, Christoph ^e   Klein, Reinhild ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GA GENERIC ASSAYS GMBH   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AIH; ASGPR; Asialoglycoprotein receptor; Autoantibody; Autoimmune hepatitis

Indexed keywords

AMINOTRANSFERASE; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEIN RECEPTOR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; GALACTOSE; RECEPTOR ANTIBODY; SEPHAROSE; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ALCOHOL LIVER DISEASE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; RABBITS; RATS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 69849089256     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.035     Document Type: Article

References (35)

1. Czaja A.J., and Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 36 (2002) 479-497
2. Czaja A.J., Bianchi F.B., and Carpenter H.A. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 41 (2005) 207-215
3. Boberg K.M., Aadland E., Jahnsen J., Raknerud N., and Stiris MBell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33 (1998) 99-103
4. Czaja A.J., dos Santos R.M., Porto A., Santrach P.J., and Moore S.B. Immune phenotype of chronic liver disease. Dig Dis Sci 43 (1998) 2149-2155
5. Al-Chalabi T., Underhill J.A., Portmann B.C., McFarlane I.G., and Heneghan M.A. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 48 (2008) 140-147
6. Stechemesser E., Klein R., and Berg P.A. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 18 (1993) 1-9
7. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Büschenfelde K.H., et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355 (2000) 1510-1515
8. Martini E., Abuaf N., Cavalli F., Durand V., Johanet C., and Homberg J.C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 8 (1988) 1662-1666
9. Krawitt E.L. Clinical features and management of autoimmune hepatitis. World J Gastroenterol 14 (2008) 3301-2205
10. Weismüller T.J., Wedemeyer J., Kubicka S., Strassburg C.P., and Manns M.P. The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48 Suppl. 1 (2008) S38-57 electronic publication 2008 Feb 11
11. Selmi C., Zuin M., and Gershwin M.E. The unfinished business of primary biliary cirrhosis. J Hepatol 49 (2008) 451-460
12. Meyer zum Büschenfelde K.H., Manns M., Hütteroth T.H., Hopf U., and Arnold W. LM-Ag and LSP-two different target antigens involved in the immunopathogenesis of chronic active hepatitis?. Clin Exp Immunol 37 (1979) 205-212
13. McFarlane I.G., McFarlane B.M., Major G.N., Tolley P., and Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 55 (1984) 347-354
14. McFarlane B.M., McSorley C.G., McFarlane I.G., and Williams B. A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein. J Immunol Methods 77 (1985) 219-228
15. Löhr H., Treichel U., Poralla T., Manns M., Meyer zum Büschenfelde K.H., and Fleischer B. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 12 (1990) 1314-1320
16. Gregorio G.V., McFarlane B., Bracken P., Vergani D., and Miele-Vergani G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 35 (2002) 515-519
17. Treichel U., Gerken G., Rossol S., Rotthauwe H.W., Meyer zum Büschenfelde K.H., and Poralla T. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 19 (1993) 55-63
18. McFarlane B.M., Sipos J., Gove C.D., McFarlane I.G., and Williams R. Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology 11 (1990) 408-415
19. Treichel U., Schreiter T., Meyer zum Büschenfelde K.H., and Stockert R.J. High-yield purification and characterization of human asialoglycoprotein receptor. Protein Expr Purif 6 (1995) 251-255
20. Schreiter T., Liu C., Gerken G., and Treichel U. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1. J Immunol Methods 301 (2005) 1-10 electronic publication 2005 Feb 17
21. Hajoui O., Martin S., and Alvarez F. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies. Clin Exp Immunol 113 (1998) 339-345
22. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
23. Halberg D.F., Wager R.E., Farrell D.C., Hildreth IV J., Quesenberry M.S., Loeb J.A., et al. Major and minor forms of the rat liver asialoglycoprotein receptor are independent galactose-binding proteins. Primary structure and glycosylation heterogeneity of minor receptor forms. J Biol Chem 262 (1987) 9828-9838
24. U. Zimny-Arndt, M. Schmid, R. Ackermann, Classical Proteomics: Two-dimensional electrophoresis/MALDI mass spectrometry. In: Lipton MS, Pasa-Tolic L, editors. Methods in Molecular Biology: Mass spectrometry of proteins and peptides. New York: Humana Press, Springer Science, 2009: 65-91.
25. Zöphel K., Wunderlich G., Kotzerke J., von Landenberg P., and Roggenbuck D. M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays. Clin Chim Acta 403 (2009) 266
26. McFarlane B.M., McSorley C.G., Vergani D., McFarlane I.G., and Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3 (1986) 196-205
27. Bogdanos D.P., Invernizzi P., Mackay I.R., and Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 14 (2008) 3374-3387
28. Bedlow A.J., Donaldson P.T., McFarlane B.M., Lombard M., McFarlane I.G., and Williams R. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. J Clin Lab Immunol 30 (1989) 103-109
29. Treichel U., McFarlane B.M., Seki T., Krawitt E.L., Alessi N., Stickel F., et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 107 (1994) 799-804
30. Pereira L.M., McFarlane B.M., Massarolo P., Saleh M.G., Bridger C., Spinelli V., et al. Specific liver autoreactivity in schistosomiasis mansoni. Trans R Soc Trop Med Hyg 91 (1997) 310-314
31. Treichel U., Poralla T., Hess G., Manns M., and Meyer zum Büschenfelde K.H. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology. 11 (1990) 606-612
32. Husa P., Chalupa P., Stroblová H., Husová L., Slesinger P., and Zajíc J. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients. Acta Virol. 45 (2001) 7-11
33. Béland K., Lapierre P., Marceau G., and Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J Autoimmun 22 (2004) 159-166
34. Vitozzi S., Lapierre P., Djilali-Saiah I., Marceau G., Beland K., and Alvarez F. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection. Autoimmunity. 37 (2004) 217-222
35. Li C.H., Xu P.S., Wang C.Y., and Zou G.L. Increased serum aminotransferases associated with anti-mitochondrial antibodiesin systemic lupus erythematosus patients with autoimmune liver disease. Clin Chim Acta 365 (2006) 135-142